Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (45)
Rongzhang Chen, Chen Feng, Lujun Chen, Xiao Zheng, Weiwei Fang, Shaoxian Wu, Xinran Gao, Can Chen, Jiayi Yang, Yue Wu, Yuanyuan Chen, Panpan Zheng, Nan Hu, Maoling Yuan, Yuanyuan Fu, Hanjie Ying, Jun Zhou & Jingting Jiang. (2024) Single-cell RNA sequencing indicates cordycepin remodels the tumor immune microenvironment to enhance TIGIT blockade's anti-tumor effect in colon cancer. International Immunopharmacology 126, pages 111268.
Crossref
Crossref
Catarina Macedo, Paulo C. Costa & Francisca Rodrigues. (2024) Bioactive compounds from Actinidia arguta fruit as a new strategy to fight glioblastoma. Food Research International 175, pages 113770.
Crossref
Crossref
Fortunato Ciardiello, Fred R. Hirsch, Robert Pirker, Enriqueta Felip, Christian Valencia & Egbert F. Smit. (2024) The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancer. Cancer Treatment Reviews 122, pages 102664.
Crossref
Crossref
Lingling Zhu, Juan Wu, Honglin Gao, Ting Wang, Guixiu Xiao, Chenggong HuQing Lin & Qinghua Zhou. (2023) Tumor immune microenvironment-modulated nanostrategy for the treatment of lung cancer metastasis. Chinese Medical Journal 136:23, pages 2787-2801.
Crossref
Crossref
Junkai Zhang, Yingyu Yang, Ying Wei, Lamei Li, Xinyi Wang & Zhihua Ye. (2023) Hsa-miR-301a-3p inhibited the killing effect of natural killer cells on non-small cell lung cancer cells by regulating RUNX3. Cancer Biomarkers 37:4, pages 249-259.
Crossref
Crossref
Wei Ye, Meiye Li & Kewang Luo. (2023) Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer. Pharmaceutics 15:7, pages 1788.
Crossref
Crossref
João P. N. Silva, Bárbara Pinto, Luís Monteiro, Patrícia M. A. Silva & Hassan Bousbaa. (2023) Combination Therapy as a Promising Way to Fight Oral Cancer. Pharmaceutics 15:6, pages 1653.
Crossref
Crossref
Md. Asad Ullah, Sayka Alam, Abu Tayab Moin, Tanvir Ahamed & Abdullah Mohammad Shohael. (2023) Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients. Computers in Biology and Medicine 158, pages 106855.
Crossref
Crossref
Yanan Cui, Peiyan Zhao, Ying Cheng & Xiubao Ren. (2023)
Potential value of efficacy prediction and treatment of
natural killer
cells in extensive stage small cell lung cancer
. Thoracic Cancer 14:10, pages 864-872.
Crossref
Crossref
Zepei Feng, Peng Huang, Jinwei Zhang, Xueshan Xia, A‐mei Zhang, Tian Zeng, Qiong Chen, Chuanlong Zhu, Weilong Tan, Yun Zhang & Ming Yue. (2023)
KIR2DL4/HLA‐G
polymorphisms were associated with HCV infection susceptibility among Chinese high‐risk population
. Journal of Medical Virology 95:3.
Crossref
Crossref
Yu Luo, Min Zhang, Zhibo Wang, Zhihua Li, Xiru Chen, Juan Cao, Jun Que, Liang Chen & Xiaheng Deng. (2023) Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association
with Tumor Mutation Burden, Prognosis, and Immune Regulation. Combinatorial Chemistry & High Throughput Screening 26:2, pages 313-329.
Crossref
Crossref
Kai Zhang, Hong Chen, Fuqiang Li, Sheng Huang, Fei Chen & Yi Li. (2023) Bright future or blind alley? CAR-T cell therapy for solid tumors. Frontiers in Immunology 14.
Crossref
Crossref
Kangdi Yang, Yuze Zhao, Guanqun Sun, Xu Zhang, Jinjin Cao, Mingcong Shao, Xijun Liang & Lina Wang. (2023) Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Aditi Sharma, Lalit Sharma, Shouvik Kumar Nandy, Nazrana Payal, Shivam Yadav, Celia Vargas-De-La-Cruz, Md. Khalid Anwer, Haroon Khan, Tapan Behl & Simona Gabriela Bungau. (2023) Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer. Molecules 28:2, pages 750.
Crossref
Crossref
Mayumi Komine. 2023.
Nami Tateyama, Hiroyuki Suzuki, Tomokazu Ohishi, Teizo Asano, Tomohiro Tanaka, Takuya Mizuno, Takeo Yoshikawa, Manabu Kawada, Mika K. Kaneko & Yukinari Kato. (2022) Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma. Pharmaceutics 14:11, pages 2494.
Crossref
Crossref
Kai Wang, Zixue Xuan, Xiaoyan Liu, Meiling Zheng, Chao Yang & Haiyong Wang. (2022) Immunomodulatory role of metalloproteinase ADAM17 in tumor development. Frontiers in Immunology 13.
Crossref
Crossref
Yifeng Shao, Wei Cao, Xinliang Gao, Mingbo Tang, Dongshan Zhu & Wei Liu. (2022) Pretreatment “prognostic nutritional index” as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis. Medicine 101:43, pages e31113.
Crossref
Crossref
Hong Wu & Yijun Nie. (2022) Proportion of natural killer cells in peripheral blood lymphocytes is correlated with cytokine levels in patients with type 2 diabetes mellitus and prediabetes: a preliminary report. International Journal of Diabetes in Developing Countries 42:4, pages 781-786.
Crossref
Crossref
Gabriele Hintzen, Holger J. Dulat & Erich Rajkovic. (2022) Engaging innate immunity for targeting the epidermal growth factor receptor: Therapeutic options leveraging innate immunity versus adaptive immunity versus inhibition of signaling. Frontiers in Oncology 12.
Crossref
Crossref
Simona Pagliuca, Carmelo Gurnari, Marie Thérèse Rubio, Valeria Visconte & Tobias L. Lenz. (2022) Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond. Frontiers in Immunology 13.
Crossref
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives. Medical Oncology 39:9.
Crossref
Crossref
Yan Fu, Yuying Chen, Zhepei Xie, Huimin Huang, Wen-Song Tan & Haibo Cai. (2022) Vitamin combination promotes ex vivo expansion of NK-92 cells by reprogramming glucose metabolism. Bioresources and Bioprocessing 9:1.
Crossref
Crossref
Yan Chen, Min Zhou, Xuyu Gu, Longfei Wang & Cailian Wang. (2022) High Expression of TACC3 Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients. Disease Markers 2022, pages 1-22.
Crossref
Crossref
Xing Jin, Zhengyang Hu, Qihai Sui, Mengnan Zhao, Jiaqi Liang, Zhenyu Liao, Yuansheng Zheng, Hao Wang & Yu Shi. (2022) A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma. Journal of Immunology Research 2022, pages 1-26.
Crossref
Crossref
Guang he Ran, Yu qing Lin, Lei Tian, Tao Zhang, Dong mei Yan, Jian hua Yu & You cai Deng. (2022) Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Maria Gemelli, Douglas M. Noonan, Valentina Carlini, Giuseppe Pelosi, Massimo Barberis, Riccardo Ricotta & Adriana Albini. (2022) Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Yi Yang, Hua Bai, Yankang Wu, Peng Chen, Jin Zhou, Jun Lei, Xiang Ye, Alex J. Brown, Xi Zhou, Ting Shu, Yongshun Chen, Pengcheng Wei & Lei Yin. (2022) Activating receptor KIR2DS2 bound to HLA‐C1 reveals the novel recognition features of activating receptor. Immunology 165:3, pages 341-354.
Crossref
Crossref
Yichun Tang, Yueyang Hu, Yuchun Niu, Lei Sun & Linlang Guo. (2022) CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer. Frontiers in Medicine 9.
Crossref
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) (Im)maturity in Tumor Ecosystem. Frontiers in Oncology 11.
Crossref
Crossref
Jiachen Lu, Jianing Ding, Zhaoxia Liu & Tingtao Chen. (2022) Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review). International Journal of Oncology 60:2.
Crossref
Crossref
Rongjiao Liu, Qizhi Luo, Weiguang Luo, Ling Wan, Quan Zhu, Xiangli Yin, Xiaofang Lu, Zixuan Song, Leiyan Wei, Zhiqing Xiang & Yizhou Zou. (2022)
A Soluble NK-CAR Mediates the Specific Cytotoxicity of NK Cells toward the Target CD20
+
Lymphoma Cells
. Aging and disease 13:5, pages 1576.
Crossref
Crossref
Eun Jae Park, Hye Won Jun, Ik Ho Na, Hong Kyung Lee, Jieun Yun, Hyung Sook Kim, Youngsoo Kim, Jin Tae Hong & Sang-Bae Han. (2021) CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity. Archives of Pharmacal Research 45:1, pages 1-10.
Crossref
Crossref
Maurice Duijvenvoorde, Sarah Derks, Idris Bahce, C René Leemans, Rieneke Ven & Marieke F Fransen. (2022) Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy. Clinical & Translational Immunology 11:1.
Crossref
Crossref
Lu Zhang, Jianlong Li, Mengzhao Zhang, Lu Wang, Tao Yang, Qiuya Shao, Xiao Liang, Minghai Ma, Nan Zhang, Minxuan Jing, Rundong Song & Jinhai Fan. (2021) Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma. Frontiers in Genetics 12.
Crossref
Crossref
Yu Zhao, Yuejiao Cao, Yiqi Chen, Lei Wu, Hua Hang, Chenxia Jiang & Xiaorong Zhou. (2021)
B2M
gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy
. Immunology 164:3, pages 507-523.
Crossref
Crossref
Morena Fasano, Francesco Perri, Carminia Maria Della Corte, Raimondo Di Liello, Giuseppina Della Vittoria Scarpati, Marco Cascella, Alessandro Ottaiano, Fortunato Ciardiello & Raffaele Solla. (2021) Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors. Biomedicines 9:8, pages 1045.
Crossref
Crossref
Meng Qiao, Tao Jiang, Xinyu Liu, Shiqi Mao, Fei Zhou, Xuefei Li, Chao Zhao, Xiaoxia Chen, Chunxia Su, Shengxiang Ren & Caicun Zhou. (2021) Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?. Journal of Thoracic Oncology 16:8, pages 1267-1288.
Crossref
Crossref
Dominik Lobinger, Jens Gempt, Wolfgang Sievert, Melanie Barz, Sven Schmitt, Huyen Thie Nguyen, Stefan Stangl, Caroline Werner, Fei Wang, Zhiyuan Wu, Hengyi Fan, Hannah Zanth, Maxim Shevtsov, Mathias Pilz, Isabelle Riederer, Melissa Schwab, Jürgen Schlegel & Gabriele Multhoff. (2021) Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Y. K Slepov, M. A Laushkin & R. V Deev. (2021) The hipotises of the immune system's role in carcinogenesis. Genes & Cells 16:1, pages 82-91.
Crossref
Crossref
Ahmet Yilmaz, Hanwei Cui, Michael A. Caligiuri & Jianhua Yu. (2020) Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Gabriele Multhoff, Sophie Seier, Stefan Stangl, Wolfgang Sievert, Maxim Shevtsov, Caroline Werner, A. Graham Pockley, Christiane Blankenstein, Martin Hildebrandt, Robert Offner, Norbert Ahrens, Konrad Kokowski, Matthias Hautmann, Claus Rödel, Rainer Fietkau, Dorota Lubgan, Rudolf Huber, Hubert Hautmann, Thomas Duell, Michael Molls, Hanno Specht, Bernhard Haller, Michal Devecka, Andreas Sauter & Stephanie E. Combs. (2020) Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial. Clinical Cancer Research 26:20, pages 5368-5379.
Crossref
Crossref
Ben Ponvilawan, Nipith Charoenngam, Pongprueth Rujirachun, Phuuwadith Wattanachayakul, Surapa Tornsatitkul, Thanitsara Rittiphairoj & Patompong Ungprasert. (2020) Chronic Hepatitis C Virus Infection is Associated with an Increased Risk of Lung Cancer: A Systematic Review and Meta-analysis. Lung 198:4, pages 705-714.
Crossref
Crossref
Zhenjie Zhuang, Qianying Chen, Cihui Huang, Junmao Wen, Haifu Huang & Zhanhua Liu. (2020) A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-17.
Crossref
Crossref
Zhanyang Fei, Dengke Li, Kaiming Li, Ming Zhou, Yong Li, Yiqun Li & Zhenxiao Sun. (2020) Detraining after tumor-bearing accelerates tumor growth while continuous training decreases tumor growth in mice. Journal of Traditional Chinese Medical Sciences 7:1, pages 75-81.
Crossref
Crossref